Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms‐Like Tyrosine Kinase‐1/Placental Growth Factor Ratio

Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms‐Like Tyrosine Kinase‐1/Placental Growth Factor Ratio

Background To study whether the use of TNF (tumor necrosis factor) inhibitors (TNFi) by pregnant women with rheumatoid arthritis affects sFlt‐1 (soluble Fms‐like tyrosine kinase‐1), PlGF (placental growth factor), or their impact on birthweight. Methods and Results sFlt‐1 and PlGF were measured in a...

Full description

Bibliographic Details
Main Authors: Cornelia H. Quaak, Anna C. M. Kluivers, Sara J. Baart, Hieronymus T. W. Smeele, Rugina I. Neuman, Langeza Saleh, Willy Visser, A. H. Jan Danser, Radboud J. E. M. Dolhain
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
birthweight
pregnancy
rheumatoid arthritis
sFlt‐1/PlGF ratio
TNF inhibitors
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032655

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.032655

Similar Items